About

Company

Molecular Imaging Diagnostics
Company in


Clinical Stage

Strong focus on


CMC

We develop platform (generally applicable) production processes allowing fast production of cold kits for new applications/sdAbs

Platform company
Detection, patient stratification and treatment evaluation
sdAb diagnostics
Cold kits with sdAbs for direct labeling
Nuclear imaging of specific immune and cancer cells

Our Edge

Technology outperforming available methods

PET/CT scan at 60–90 min. post injection of radiotracer
Low irradiation burden
Specific and sensitive target identification
No complex patient preparation needed
Development of “lyophilized kit formulation”
Simple to use
Long-term stability
Affordable price
Available at any time + any nuclear medicine department

Team

Karine
Clauwaert
CEO
BD specialist
Tony
Lahoutte
Medical Director
Martine Vandermarliere
CSO
CMC protein
Philippe Van Wolleghem
CTO
CMC radio
Henri
Baudhuin
Scientist
Preclinical

Contact

ABSCINT NV
BTW nummer: BE 0749.828.410

HQ
Broustinlaan 67
1083 Ganshoren
Email: info@abscint.com

Exploitation site
Avenue du Parc Industriel 89,
4041 Herstal